Preoperative predictors of clinically relevant residual fragments after flexible ureteroscopy for renal stones ≤ 20 mm: a routine-care cohort study
Stone-free outcomes after flexible ureteroscopy (fURS) vary partly because follow-up imaging and residual-fragment thresholds are inconsistent. We evaluated preoperative predictors of clinically relevant residual fragments under routine-care follow-up. We conducted a single-center prospective prgamatic cohort of consecutive adults undergoing fURS with Holmium: YAG laser lithotripsy for renal stones with largest single-stone diameter ≤ 20 mm (January 2019–December 2025). Patients were analyzed if postoperative imaging was available within 8–16 weeks. The primary endpoint was routine-care assessed residual fragment > 4 mm on follow-up imaging (ultrasound/KUB and/or low-dose non-contrast CT [NCCT]) as performed in routine care. A prespecified parsimonious multivariable logistic regression model included cumulative stone diameter, multiple stones, lower-pole location, and moderate–severe hydronephrosis; missing covariates were multiply imputed. Of 331 screened procedures, 298 patients were analyzed (mean age 49.3 years; 171/298 [57.4%] were men). Follow-up imaging comprised NCCT in 126 and ultrasound/KUB alone in 172 at a median of 12.5 weeks. Residual fragments > 4 mm were detected in 28/126 (22.2%) patients with NCCT follow-up and 26/172 (15.1%) patients with ultrasound/KUB alone. Residual fragment > 4 mm occurred in 54/298 (18.1%), corresponding to a clinical stone-free rate (≤ 4 mm) of 81.9% (95% CI 77.0–86.1). Residual fragment > 4 mm was associated with higher stone burden (per 5-mm increase in cumulative stone diameter: adjusted OR 1.44, 95% CI 1.05–1.99; p = 0.024), multiple stones (adjusted OR 1.88, 95% CI 1.01–3.53; p = 0.048), and lower-pole location (adjusted OR 2.65, 95% CI 1.42–4.94; p = 0.002). In routine-care follow-up after fURS for renal stones with largest single-stone diameter ≤ 20 mm, stone burden, multiplicity, and lower-pole location were independently associated with higher odds of clinically relevant residual fragments.
Authors
- Chen Chen (ORCID: https://orcid.org/0000-0003-4569-6032)
- Qiang Yuan (ORCID: https://orcid.org/0000-0003-2356-5314)
- Jian Yang
- Xing Liu
- Minghui Wu
Institutions
- Sichuan Mianyang 404 Hospital (CN)
Publication Details
- Journal
- BMC Urology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1186/s12894-026-02397-7
- Primary Topic
- Kidney Stones and Urolithiasis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00